Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1358820 (Botox) in post-stroke lower limb spasticity
NCT00460655Phase 3Completed
- Sponsor
- GSK
- Start
- May 2007
- Primary completion
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in Lower limb spasticity, sponsored by GSK. Started May 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Lower limb spasticity
Beyond the preview
Go deeper on NCT00460655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460655.